FEDERICO
GARRIDO TORRES-PUCHOL
Investigador desde 2023
MARÍA TERESA
CABRERA CASTILLO
CATEDRÁTICA DE UNIVERSIDAD
Publicaciones en las que colabora con MARÍA TERESA CABRERA CASTILLO (72)
2016
-
Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance
Cancer Immunology, Immunotherapy, Vol. 65, Núm. 1, pp. 47-59
2013
-
MHC class i antigens and the tumor microenvironment
The Tumor Immunoenvironment (Springer Netherlands), pp. 253-286
2012
-
Cancer immune escape: Implications for immunotherapy, Granada, Spain, October 3-5, 2011
Cancer Immunology, Immunotherapy
-
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
International Journal of Cancer, Vol. 131, Núm. 2, pp. 387-395
2011
-
Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells
International Journal of Cancer, Vol. 129, Núm. 4, pp. 839-846
-
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
Immunogenetics, Vol. 63, Núm. 2, pp. 65-71
-
Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity
Cancer Immunology, Immunotherapy, Vol. 60, Núm. 6, pp. 869-882
2010
-
"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
International Journal of Cancer
-
Analysis of HLA-ABC locus-specific transcription in normal tissues
Immunogenetics, Vol. 62, Núm. 11-12, pp. 711-719
-
Higher HLA class i expression in renal cell carcinoma than in autologous normal tissue
Tissue Antigens, Vol. 75, Núm. 2, pp. 110-118
2009
-
HLA and melanoma: Multiple alterations in HLA class i and II expression in human melanoma cell lines from ESTDAB cell bank
Cancer Immunology, Immunotherapy, Vol. 58, Núm. 9, pp. 1507-1515
2008
-
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
Immunogenetics, Vol. 60, Núm. 8, pp. 439-447
-
HLA class I expression, tumor escape and cancer progression
Current Cancer Therapy Reviews, Vol. 4, Núm. 2, pp. 105-110
-
Regressing and progressing metastatic lesions: Resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
Cancer Immunology, Immunotherapy
2007
-
Analysis of HLA class I alterations in tumors: Choosing a strategy based on known patterns of underlying molecular mechanisms
Tissue Antigens
-
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours
Tissue Antigens, Vol. 69, Núm. 3, pp. 220-226
-
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination
Cancer Immunology, Immunotherapy, Vol. 56, Núm. 5, pp. 709-717
-
International conference: Progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain
Cancer Immunology, Immunotherapy
-
MHC Class I Antigens and Immune Surveillance in Transformed Cells
International Review of Cytology, Vol. 256, pp. 139-189
-
Role of altered expression of HLA class i molecules in cancer progression
Advances in Experimental Medicine and Biology